Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus …
(1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-
susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and …
susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and …
Heartbreaking decisions: The dogma and uncertainties of antimicrobial therapy in infective endocarditis
JL Adema, A Ahiskali, M Fida, K Mediwala Hornback… - Pathogens, 2023 - mdpi.com
Infective endocarditis (IE) is a rare but increasingly prevalent disease with high morbidity
and mortality, requiring antimicrobials and at times surgical intervention. Through the …
and mortality, requiring antimicrobials and at times surgical intervention. Through the …
Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs
JA Wildenthal, A Atkinson, S Lewis… - Clinical infectious …, 2023 - academic.oup.com
Background Staphylococcus aureus represents the leading cause of complicated
bloodstream infections among persons who inject drugs (PWID). Standard of care (SOC) …
bloodstream infections among persons who inject drugs (PWID). Standard of care (SOC) …
Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus …
Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia is associated with poor
outcomes. Ceftriaxone offers logistical advantages over other standard therapies, though in …
outcomes. Ceftriaxone offers logistical advantages over other standard therapies, though in …
Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta …
Optimal therapy for methicillin-susceptible Staphylococcus aureus (MSSA) infections is
unclear. Current standard of care consists of antistaphylococcal antibiotics (ASAs) such as …
unclear. Current standard of care consists of antistaphylococcal antibiotics (ASAs) such as …
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study
DTP Buis, TW Van Der Vaart, JM Prins… - Journal of …, 2023 - academic.oup.com
Objectives Standard once-daily dosing of ceftriaxone may not lead to adequate antibiotic
exposure in all cases of Staphylococcus aureus bacteraemia (SAB). Therefore, we …
exposure in all cases of Staphylococcus aureus bacteraemia (SAB). Therefore, we …
Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan
S Tsuzuki, J Yu, N Matsunaga, N Ohmagari - Public Health, 2021 - Elsevier
Objectives To examine the length of stay, hospitalisation costs and case fatality of methicillin-
susceptible and-resistant Staphylococcus aureus (MSSA and MRSA) bacteremia in Japan …
susceptible and-resistant Staphylococcus aureus (MSSA and MRSA) bacteremia in Japan …
Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive Staphylococcus aureus Bloodstream …
Y Hamad, KB Nickel, MA Olsen… - Open Forum Infectious …, 2024 - academic.oup.com
Background Ceftriaxone is a convenient option for methicillin-sensitive Staphylococcus
aureus (MSSA) outpatient parenteral antimicrobial therapy (OPAT), but population-based …
aureus (MSSA) outpatient parenteral antimicrobial therapy (OPAT), but population-based …
Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections: A Noninferiority Retrospective Cohort …
Background: Antistaphylococcal penicillins and cefazolin are the treatments of choice for
methicillin-susceptible Staphylococcus aureus (MSSA) infections, requiring multiple doses …
methicillin-susceptible Staphylococcus aureus (MSSA) infections, requiring multiple doses …
Clinical outcomes of an innovative cefazolin delivery program for MSSA infections in OPAT
L Herrera-Hidalgo, R Luque-Márquez… - Journal of Clinical …, 2022 - mdpi.com
Cefazolin is a recommended treatment for methicillin-susceptible Staphylococcus aureus
(MSSA) infections that has been successfully used in outpatient parenteral antibiotic therapy …
(MSSA) infections that has been successfully used in outpatient parenteral antibiotic therapy …